Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Methylphenidate 💬
(Methylphenidate (USAN/INN), METHYLPHENIDATE, METHYLPHENIDATE TRANSDERMAL SYSTEM)
[1] Methylphenidate (Methylphenidate)[2] Methylphenidate; Methylphenidate hydrochloride[2] SLC6A2,
SLC6A3 💬
[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[5] 6, 13, 34, 84, 113 💬
2 Methylphenidate hydrochloride 💬
(Methylphenidate hydrochloride (JAN/USP), METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HCL, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)
[1] Methylphenidate (Methylphenidate)[2] Methylphenidate; Methylphenidate hydrochloride[2] SLC6A2,
SLC6A3 💬
[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[5] 6, 13, 34, 84, 113 💬